Annual Drug Patent Expirations for THALOMID
Thalomid is a drug marketed by Celgene and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug and three Paragraph IV challenges.
Drug patent litigation for THALOMID.
This drug has forty-four patent family members in nineteen countries.
The generic ingredient in THALOMID is thalidomide. One supplier is listed for this compound. Additional details are available on the thalidomide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
